Published in Arch Dis Child on October 01, 2002
Pediatric body composition analysis with dual-energy X-ray absorptiometry. Pediatr Radiol (2009) 1.91
Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study. Pediatrics (2008) 1.48
Pediatric DXA: technique and interpretation. Pediatr Radiol (2006) 1.34
Association of chronic kidney disease with muscle deficits in children. J Am Soc Nephrol (2010) 1.27
Distal radius in adolescent girls with anorexia nervosa: trabecular structure analysis with high-resolution flat-panel volume CT. Radiology (2008) 1.23
UK reference data for the Hologic QDR Discovery dual-energy x ray absorptiometry scanner in healthy children and young adults aged 6-17 years. Arch Dis Child (2006) 1.12
Effects of higher dietary protein intake on energy balance and metabolic control in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency. Mol Genet Metab (2006) 1.03
Poor physical function in elderly women in low-level aged care is related to muscle strength rather than to measures of sarcopenia. Clin Interv Aging (2011) 0.99
Age-related distribution of bone and skeletal parameters in 1,322 Japanese young women. J Bone Miner Metab (2009) 0.97
Corticosteroid use and bone mineral accretion in children with asthma: effect modification by vitamin D. J Allergy Clin Immunol (2012) 0.95
Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia. Haematologica (2009) 0.94
Body composition and nutritional intake in children with chronic kidney disease. Pediatr Nephrol (2006) 0.91
Immature mice are more susceptible to the detrimental effects of high fat diet on cancellous bone in the distal femur. Bone (2013) 0.90
The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy. Osteoporos Int (2012) 0.88
Obesity is underestimated using body mass index and waist-hip ratio in long-term adult survivors of childhood cancer. PLoS One (2012) 0.88
The negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia. Haematologica (2014) 0.88
Biomarkers of Environmental Enteropathy, Inflammation, Stunting, and Impaired Growth in Children in Northeast Brazil. PLoS One (2016) 0.87
Seropositivity to celiac antigens in asymptomatic children with type 1 diabetes mellitus: association with weight, height, and bone mineralization. Pediatr Diabetes (2008) 0.86
How Young is "Too Young" to Start Training? ACSMs Health Fit J (2013) 0.85
Toward body composition reference data for infants, children, and adolescents. Adv Nutr (2014) 0.85
Development of a beta-trace protein based formula for estimation of glomerular filtration rate. Pediatr Nephrol (2009) 0.85
Iliac bone histomorphometry in children with newly diagnosed inflammatory bowel disease. Osteoporos Int (2009) 0.84
Fibroblast growth factor 23 contributes to diminished bone mineral density in childhood inflammatory bowel disease. BMC Gastroenterol (2012) 0.84
Prevalence of vitamin D insufficiency in Swiss teenagers with appendicular fractures: a prospective study of 100 cases. J Child Orthop (2012) 0.83
How does long-term parenteral nutrition impact the bone mineral status of children with intestinal failure? J Bone Miner Metab (2009) 0.83
Early decrements in bone density after completion of neoadjuvant chemotherapy in pediatric bone sarcoma patients. BMC Musculoskelet Disord (2010) 0.83
LEOPARD syndrome-associated SHP2 mutation confers leanness and protection from diet-induced obesity. Proc Natl Acad Sci U S A (2014) 0.82
Muscle weakness as presenting symptom of osteogenesis imperfecta. Eur J Pediatr (2006) 0.82
The choice of normative pediatric reference database changes spine bone mineral density Z-scores but not the relationship between bone mineral density and prevalent vertebral fractures. J Clin Endocrinol Metab (2014) 0.82
Assessment of bone mass following renal transplantation in children. Pediatr Nephrol (2005) 0.82
Use of fat mass and fat free mass standard deviation scores obtained using simple measurement methods in healthy children and patients: comparison with the reference 4-component model. PLoS One (2013) 0.81
The muscle-bone unit of peripheral and central skeletal sites in children and young adults. Osteoporos Int (2010) 0.81
Abdominal radiotherapy: a major determinant of metabolic syndrome in nephroblastoma and neuroblastoma survivors. PLoS One (2012) 0.81
Body composition profile of young patients with phenylketonuria and mild hyperphenylalaninemia. Int J Endocrinol Metab (2014) 0.80
Bone mineral content, corrected for height or bone area, measured by DXA is not reduced in children with chronic renal disease or in hypoparathyroidism. Pediatr Nephrol (2005) 0.80
Direct X-ray radiogrammetry versus dual-energy X-ray absorptiometry: assessment of bone density in children treated for acute lymphoblastic leukaemia and growth hormone deficiency. Pediatr Radiol (2006) 0.80
Bone density at the os calcis: reference values, reproducibility, and effects of fracture history and physical activity. Arch Dis Child (2005) 0.79
Well-nourished cystic fibrosis patients have normal mineral density, but reduced cortical thickness at the forearm. Osteoporos Int (2008) 0.79
Bone mineral density after bone marrow transplantation in childhood: measurement and associations. Biol Blood Marrow Transplant (2010) 0.79
Vertebral fractures despite normal spine bone mineral density in a boy with nephrotic syndrome. Pediatr Nephrol (2010) 0.79
Racial difference in the correlates of bone mineral content/density and age at peak among reproductive-aged women. Osteoporos Int (2009) 0.78
Metabolic control and bone health in adolescents with type 1 diabetes. Int J Pediatr Endocrinol (2011) 0.78
Increased circulating IL-8 is associated with reduced IGF-1 and related to poor metabolic control in adolescents with type 1 diabetes mellitus. Cytokine (2009) 0.78
Growth hormone treatment in children with rheumatic disease, corticosteroid induced growth retardation, and osteopenia. Arch Dis Child (2005) 0.78
Body composition and bone density reference data for Korean children, adolescents, and young adults according to age and sex: results of the 2009-2010 Korean National Health and Nutrition Examination Survey (KNHANES). J Bone Miner Metab (2015) 0.77
Lumbar spine and total-body dual-energy X-ray absorptiometry in children with severe neurological impairment and intellectual disability: a pilot study of artefacts and disrupting factors. Pediatr Radiol (2012) 0.77
The metabolic syndrome and body composition in childhood cancer survivors. Korean J Pediatr (2011) 0.77
Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia. Haematologica (2015) 0.76
Bone Health in Childhood: Usefulness of Biochemical Biomarkers. EJIFCC (2008) 0.75
Bone histomorphometric changes in children with rheumatic disorders on chronic glucocorticoids. Pediatr Rheumatol Online J (2016) 0.75
Percentile curves for skinfold thickness for Canadian children and youth. PeerJ (2016) 0.75
A Piece of the Puzzle: The Bone Health Index of the BoneXpert Software Reflects Cortical Bone Mineral Density in Pediatric and Adolescent Patients. PLoS One (2016) 0.75
Body composition analysis by dual-energy X-ray absorptiometry in young preschool children. Eur J Clin Nutr (2016) 0.75
Automated radiogrammetry is a feasible method for measuring bone quality and bone maturation in severely disabled children. Pediatr Radiol (2016) 0.75
Body composition predictors of skeletal integrity in obesity. Skeletal Radiol (2016) 0.75
The time to and determinants of first fractures in boys with Duchenne muscular dystrophy. Osteoporos Int (2016) 0.75
Bone marrow fat content in 70 adolescent girls with anorexia nervosa: Magnetic resonance imaging and magnetic resonance spectroscopy assessment. Pediatr Radiol (2017) 0.75
Micronutrients, Essential Fatty Acids and Bone Health in Phenylketonuria. Ann Nutr Metab (2017) 0.75
Variation in lumbar spine bone mineral content by age and gender in apparently healthy Indians. J Bone Miner Metab (2009) 0.75
Neonatal anthropometrics and body composition in obese children investigated by dual energy X-ray absorptiometry. Eur J Pediatr (2013) 0.75
Relationships between the lean mass index and bone mass and reference values of muscular status in healthy Chinese children and adolescents. J Bone Miner Metab (2015) 0.75
Musculoskeletal health in newly diagnosed children with Crohn's disease. Osteoporos Int (2017) 0.75
Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child (1976) 12.33
Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet (1993) 9.34
Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med (1991) 5.83
The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone (1995) 5.76
Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr (1990) 4.82
New approaches for interpreting projected bone densitometry data. J Bone Miner Res (1992) 3.12
Adolescents' self-assessment of sexual maturation. Pediatrics (1980) 3.06
Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinants. Am J Clin Nutr (1994) 2.81
Bone gain in young adult women. JAMA (1992) 2.73
Changes in vertebral bone density in black girls and white girls during childhood and puberty. N Engl J Med (1991) 2.70
Whole body bone mineral content in healthy children and adolescents. Arch Dis Child (1997) 2.36
Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest (1994) 2.33
Growth hormone and bone. Endocr Rev (1998) 2.28
More broken bones: a 4-year double cohort study of young girls with and without distal forearm fractures. J Bone Miner Res (2000) 1.76
Bone densitometry of the spine and femur in children by dual-energy x-ray absorptiometry. Bone Miner (1992) 1.61
Bone mineral density in children and adolescents: relation to puberty, calcium intake, and physical activity. J Clin Endocrinol Metab (1997) 1.57
Construction of age-related reference centiles using absolute residuals. Stat Med (1993) 1.52
Measurement of volumetric bone mineral density accurately determines degree of lumbar undermineralization in children with growth hormone deficiency. J Clin Endocrinol Metab (1998) 1.49
Precision and stability of dual-energy X-ray absorptiometry measurements. Calcif Tissue Int (1991) 1.26
Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopenia. J Pediatr (1999) 1.26
Cross-calibration of fat and lean measurements by dual-energy X-ray absorptiometry to pig carcass analysis in the pediatric body weight range. Am J Clin Nutr (1996) 1.22
Peak trabecular vertebral density: a comparison of adolescent and adult females. Calcif Tissue Int (1988) 1.21
Measured and predicted bone mineral content in healthy boys and girls aged 6-18 years: adjustment for body size and puberty. Acta Paediatr (1998) 1.15
Bone mineral density in two different socio-economic population groups. Bone Miner (1992) 1.15
Bone mineral and calcium accretion during puberty. Am J Clin Nutr (1997) 1.14
Detection of small changes in body composition by dual-energy x-ray absorptiometry. Am J Clin Nutr (1993) 1.14
Bone mineral density of total body, spine, and femoral neck in children and young adults: a cross-sectional and longitudinal study. J Bone Miner Res (1994) 1.14
Bone mineral acquisition during adolescence and early adulthood: a study in 574 healthy females 10-24 years of age. Osteoporos Int (1996) 1.12
Comparison of different models for interpreting bone mineral density measurements using DXA and MRI technology. Bone (1995) 1.08
Determinants of body composition measured by dual-energy X-ray absorptiometry in Dutch children and adolescents. Am J Clin Nutr (1997) 1.06
Determination of body composition--a comparison of dual-energy x-ray absorptiometry and hydrodensitometry. Am J Clin Nutr (1993) 0.98
The role of estrogen in pubertal skeletal physiology: epiphyseal maturation and mineralization of the skeleton. Acta Paediatr (1995) 0.93
Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J Clin Endocrinol Metab (1997) 0.92
Evaluation of low density spine software for the assessment of bone mineral density in children. J Bone Miner Res (1998) 0.88
Normalization of spine densitometry. J Bone Miner Res (1994) 0.84
Premenopausal bone loss in the lumbar spine and neck of femur: a study of 225 Caucasian women. Bone (1990) 0.84
Late consequences of a low peak bone mass. Acta Paediatr Suppl (1995) 0.82
Lumbar spine bone density in Argentine children. Calcif Tissue Int (1996) 0.79
Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med (1990) 2.85
[Seizures in foreign newborns due to maternal vitamin-D deficiency]. Ned Tijdschr Geneeskd (2005) 2.65
Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology (2005) 2.49
Developing evidence-based guidelines for referral for short stature. Arch Dis Child (2007) 2.49
The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev (1991) 2.20
Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. N Engl J Med (1989) 2.13
[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients. Eur J Nucl Med (2001) 2.11
Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion. Am J Med (1994) 1.93
In vivo radionuclide uptake quantification using a multi-pinhole SPECT system to predict renal function in small animals. Eur J Nucl Med Mol Imaging (2006) 1.81
Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy. J Clin Endocrinol Metab (1990) 1.71
Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev (2001) 1.69
Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate. Eur J Nucl Med Mol Imaging (2003) 1.66
Somatostatin-receptor scintigraphy in primary breast cancer. Lancet (1994) 1.63
Bone mineral density in children and adolescents: relation to puberty, calcium intake, and physical activity. J Clin Endocrinol Metab (1997) 1.57
Peptide receptor imaging and therapy. J Nucl Med (2000) 1.54
[177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy. Int J Cancer (2001) 1.53
[(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas. J Clin Endocrinol Metab (2001) 1.50
Gene transcript analysis blood values correlate with ⁶⁸Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status. Eur J Nucl Med Mol Imaging (2015) 1.41
In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man. J Nucl Med (1991) 1.41
Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain. J Am Coll Cardiol (1996) 1.40
[Insulinoma and octreotide]. Ned Tijdschr Geneeskd (1992) 1.38
Hepatobiliary handling of iodine-125-Tyr3-octreotide and indium-111-DTPA-D-Phe1-octreotide by isolated perfused rat liver. J Nucl Med (1993) 1.38
Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. J Clin Endocrinol Metab (1997) 1.38
Place of radioactive iodine in treatment of thyrotoxicosis. Lancet (1986) 1.30
Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives. Eur J Nucl Med (2001) 1.30
Lutetium-labelled peptides for therapy of neuroendocrine tumours. Eur J Nucl Med Mol Imaging (2012) 1.25
Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide. J Nucl Med (2001) 1.25
Maternal smoking and fetal growth characteristics in different periods of pregnancy: the generation R study. Am J Epidemiol (2007) 1.24
Somatostatin analogue scintigraphy in carcinoid tumours. Eur J Nucl Med (1993) 1.24
The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol (Oxf) (1993) 1.20
Octreotide scintigraphy for the detection of paragangliomas. J Nucl Med (1993) 1.20
Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy. Cancer Res (1998) 1.13
Thyroid hormone transport by the heterodimeric human system L amino acid transporter. Endocrinology (2001) 1.12
Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy. Int J Cancer (2000) 1.11
Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in patients with Alzheimer's disease: effects of region of interest selection. Eur J Nucl Med (1994) 1.10
The effect of etanercept on Graves' ophthalmopathy: a pilot study. Eye (Lond) (2005) 1.09
Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in rats. J Nucl Med (1995) 1.08
Ontogeny of iodothyronine deiodinases in human liver. J Clin Endocrinol Metab (1998) 1.08
Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor size. J Nucl Med (2001) 1.07
Somatostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med (1994) 1.07
High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature. Arch Dis Child (2002) 1.06
Determinants of body composition measured by dual-energy X-ray absorptiometry in Dutch children and adolescents. Am J Clin Nutr (1997) 1.06
Comparison of [(177)Lu-DOTA(0),Tyr(3)]octreotate and [(177)Lu-DOTA(0),Tyr(3)]octreotide: which peptide is preferable for PRRT? Eur J Nucl Med Mol Imaging (2006) 1.05
A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer (2009) 1.05
Inherited thyroxine excess: a serum abnormality due to an increased affinity for modified albumin. Clin Endocrinol (Oxf) (1981) 1.05
Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut (1998) 1.04
Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy. Eur J Nucl Med (1997) 1.04
In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats. Life Sci (1991) 1.04
Somatostatin and the immune and haematopoetic system; a review. Eur J Clin Invest (1994) 1.04
Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amount. Eur J Nucl Med (1999) 1.04
Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol (2000) 1.03
Thyroxine and 3,3',5-triiodothyronine are glucuronidated in rat liver by different uridine diphosphate-glucuronyltransferases. Endocrinology (1991) 1.01
Peptide receptor imaging of prostate cancer with radiolabelled bombesin analogues. Methods (2009) 1.00
Identification of thyroid hormone transporters. Biochem Biophys Res Commun (1999) 1.00
Active transport of triiodothyronine (T3) into isolated rat liver cells. FEBS Lett (1978) 1.00
Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours. Eur J Nucl Med Mol Imaging (2007) 0.99
Effects of immunoscintigraphy with monoclonal antibodies in assays of hormones and tumour markers. BMJ (1989) 0.98
Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer. Eur J Nucl Med Mol Imaging (2003) 0.98
In vivo somatostatin receptor imaging in medullary thyroid carcinoma. J Clin Endocrinol Metab (1993) 0.98
D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake. J Nucl Med (1997) 0.97
Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty. J Clin Endocrinol Metab (1998) 0.97
Vascular risk factors, atherosclerosis, cerebral white matter lesions and cerebral perfusion in a population-based study. Eur J Nucl Med (1996) 0.96
Neuroendocrine tumors and somatostatin: imaging techniques. J Endocrinol Invest (2005) 0.96
Deiodination of thyroid hormone by human liver. J Clin Endocrinol Metab (1988) 0.95
Growth monitoring and diagnostic work-up of short stature: an international inventorization. J Pediatr Endocrinol Metab (2005) 0.94
Echocardiographic and radionuclide pulmonary blood flow patterns after transcatheter closure of patent ductus arteriosus. Circulation (1996) 0.94
Uptake of triiodothyroacetic acid and its effect on thyrotropin secretion in cultured anterior pituitary cells. Endocrinology (1994) 0.94
Evaluation in vitro and in rats of 161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy. Eur J Nucl Med (1995) 0.94
Somatostatin receptor scintigraphy in patients with carcinoid tumors. World J Surg (1996) 0.94
Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides. Nucl Med Biol (2008) 0.93
Vitamin D receptor gene polymorphism predicts height and bone size, rather than bone density in children and young adults. Calcif Tissue Int (2003) 0.93
Improved control of severe hypoglycemia in patients with malignant insulinomas by peptide receptor radionuclide therapy. J Clin Endocrinol Metab (2011) 0.93
Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J Clin Endocrinol Metab (1997) 0.92
Molecular imaging of reduced renal uptake of radiolabelled [DOTA0,Tyr3]octreotate by the combination of lysine and Gelofusine in rats. Nuklearmedizin (2008) 0.92
Octreotide and related somatostatin analogs in the diagnosis and treatment of pituitary disease and somatostatin receptor scintigraphy. Front Neuroendocrinol (1993) 0.91
Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism: proof of principle. Thyroid (2004) 0.91
Digital radiogrammetry of the hand in a pediatric and adolescent Dutch Caucasian population: normative data and measurements in children with inflammatory bowel disease and juvenile chronic arthritis. Calcif Tissue Int (2004) 0.91
Internalization of radiolabelled [DTPA0]octreotide and [DOTA0,Tyr3]octreotide: peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy. Nucl Med Commun (1998) 0.91
Somatostatin analogue scintigraphy. A simple and sensitive method for the in vivo visualization of Merkel cell tumors and their metastases. Arch Dermatol (1992) 0.90
Bone mineral density and body composition and influencing factors in children with rheumatic diseases treated with corticosteroids. J Pediatr Endocrinol Metab (2002) 0.90
In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas. Int J Cancer (1992) 0.90
Germline variation in the MTHFR and MTRR genes determines the nadir of bone density in pediatric acute lymphoblastic leukemia: a prospective study. Bone (2010) 0.89
Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo. J Nucl Med (1996) 0.89
Somatostatin receptor imaging in patients with sarcoidosis. Eur J Nucl Med (1998) 0.89
Treatment with Sandostatin and in vivo localization of tumors with radiolabeled somatostatin analogs. Metabolism (1990) 0.89
Comparison of dobutamine stress echocardiography and technetium-99m sestamibi single-photon emission tomography for the diagnosis of coronary artery disease in hypertensive patients with and without left ventricular hypertrophy. Eur J Nucl Med (1998) 0.89
The value of octreotide scintigraphy in patients with lung cancer. Eur J Nucl Med (1994) 0.88
Induction of puberty in the hypogonadal girl--practices and attitudes of pediatric endocrinologists in Europe. Horm Res (2002) 0.88
Regional cerebral blood flow and cerebrovascular risk factors in the elderly population. Neurobiol Aging (1998) 0.88
Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects. J Clin Endocrinol Metab (2013) 0.87
Radioiodinated somatostatin analog scintigraphy in small-cell lung cancer. J Nucl Med (1991) 0.87
The impact of APOE on myocardial infarction, stroke, and dementia: the Rotterdam Study. Neurology (2004) 0.87
Regulation of hormone release by cultured cells from a thyrotropin-growth hormone-secreting pituitary tumor. Direct inhibiting effects of 3,5,3'-triiodothyronine and dexamethasone on thyrotropin secretion. J Endocrinol Invest (1984) 0.87
Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy. J Nucl Med (1999) 0.87
Fertility potential in men with a history of congenital undescended testes: a long-term follow-up study. Andrology (2012) 0.87
Accuracy of exercise stress technetium 99m sestamibi SPECT imaging in the evaluation of the extent and location of coronary artery disease in patients with an earlier myocardial infarction. J Nucl Cardiol (2001) 0.87
Bone density and body composition in chronic renal failure: effects of growth hormone treatment. Pediatr Nephrol (2000) 0.87